ACM
AUTL

Aquatic Capital Management’s Autolus Therapeutics AUTL Stock Holding History

Aquatic Capital Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-114,398
Closed -$158K – 1259
2026
Q1 		$158K Buy
+114,398
New +$174K ﹤0.01% 1031
2025
Q4 		– Sell
-104,684
Closed -$171K – 1401
2025
Q3 		$171K Buy
+104,684
New +$205K ﹤0.01% 1122
2024
Q2 		– Sell
-3,100
Closed -$19.8K – 1224
2024
Q1 		$19.8K Buy
+3,100
New +$19.3K ﹤0.01% 1100

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Aquatic Capital Management's AUTL Position: Q2 2026 in Review

Aquatic Capital Management sold out of Autolus Therapeutics (AUTL) in Q2 2026, closing a stake of 114,398 shares — an estimated $158K sold.

Aquatic Capital Management first reported a position in AUTL in Q1 2024 and held it in 3 quarters. The position peaked at $171K in Q3 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Aquatic Capital Management reported no remaining Autolus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 114,398 Autolus Therapeutics shares in Q2 2026, an estimated $158K.
  • Aquatic Capital Management first reported a position in Autolus Therapeutics in Q1 2024 and held it in 3 quarters.
  • Aquatic Capital Management's Autolus Therapeutics position peaked at $171K in Q3 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.